Indrayani Biotech Limited - agriculture in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN L40100TN1992PLC129301 Incorporated 09 March 1992 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Listed - BSE: 526445 Public Limited Company agriculture
Data last updated
Revenue · FY 2025
₹130.23 Cr
▼ 21.66% YoY
Computed EBITDA · FY 2025
₹9.39 Cr
▼ 61.93% YoY
Net profit · FY 2025
-₹6.11 Cr
▼ 158.6% YoY
Authorised capital
₹65 Cr
Registered with MCA
Paid-up capital
₹45.54 Cr
Issued & subscribed
Open charges
₹23.62 Cr
Satisfied ₹1.16 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
445
Latest available

About Indrayani Biotech Limited

Data last updated: 14 July 2026

Indrayani Biotech Limited is a public limited company based in Chennai, Tamil Nadu, India. It specialises in fertilizers and soil enhancers, a part of the broader agriculture sector. Incorporated on 09 March 1992, the company has been in operation for over 34 years.

Registered with ROC Chennai under CIN L40100TN1992PLC129301. Listed on BSE: 526445.

Capital: an authorised share capital of ₹65 Cr and a paid-up capital of ₹45.54 Cr. It is led by directors including Nangavaram Mahadevan Ranganathan and Kannimangalam Subramanyan Vaidyanathan.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2024. Office: Chennai, Tamil Nadu.

As per BSE-filed consolidated financials for FY 2025, the company reported a revenue of ₹130.23 Cr, a decline of 21.66% compared to the previous year. The net worth stands at ₹99.92 Cr (up 31.01% YoY). Total assets are valued at ₹268.17 Cr (up 14.1% YoY).

The company has a workforce of approximately 445 employees as per the latest available data. Its group structure includes 9 subsidiaries.

The company is associated with 1 brand - Indrayani Biotech. As per MCA filings, the company has open charges of ₹23.62 Cr and satisfied charges of ₹1.16 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indrayani.com.

Company Details of Indrayani Biotech Limited
CIN L40100TN1992PLC129301
Registration Number 129301
Incorporation Date 09 March 1992
ROC Chennai
Listing Status Listed (BSE: 526445)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Block 1 Module No.33 3Rd Floor Sidco Electronic Complex Thiru Vi Ka Industrial Estate G, Uindy, Chennai, Tamil Nadu, India – 600032
  • Industry
    Agriculture, Fertilizers & Soil Enhancers
Company report
Indrayani Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Indrayani Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Indrayani Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Indrayani Biotech Limited

Indrayani Biotech Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L40100TN1992PLC129301, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L40100TN1992PLC129301 Current
L40100PN1992PLC065801 Previous
L24231PN1992PLC065801 Previous

Associated Brands with Indrayani Biotech Limited

Indrayani Biotech Limited operates one associated brand: Indrayani Biotech. These brands represent Indrayani Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Diversified crop nutrition and protection solutions are provided for farmers. indrayani.com

Competitors & Alternatives of Indrayani Biotech Limited

Brands and companies operating in the same space as Indrayani Biotech Limited include Titan Biotech, IPL Biologicals, Univia and 7 more.

Competitor Description Location Founded
Titan Biotech Titan Biotech Biological products are manufactured and exported for various industries. Delhi, India, India 1992
IPL Biologicals IPL Biologicals Plant nutrition and protection products are manufactured and supplied. Gurugram, India, India 1994
Univia Univia Agri-input retailers are connected to farmers via a phygital network. Ahmedabad, India, India 2020
Sri Biotech Laboratories Sri Biotech Laboratories Crop improvement research and nutrient manufacturing are conducted. Hyderabad, India, India 1994
Capsber Capsber Diversified crop biological solutions are provided for farmers. Bengaluru, India, India 2022
Lab2Land Lab2Land Agrochemicals, fertilizers, and crop nutrition solutions are researched and developed. Hyderabad, India, India 2020
Criyagen Criyagen Develops innovative technologies for organic and bio-active farm inputs. Bengaluru, India, India 2008
Shivashakthi BioTechnologies Shivashakthi BioTechnologies Development and commercial production of plantlets and farm inputs Hyderabad, India, India 2001
Varsha Bioscience and Technology Varsha Bioscience and Technology Bio-pesticides, bio-fertilizers, and plant growth promoters are manufactured. Hyderabad, India, India 2003
Gokulam Biotech Gokulam Biotech Develops liquid-based bio products for organic farming and agriculture. Puducherry, India, India 2002

Business Activity of Indrayani Biotech Limited

Indrayani Biotech Limited is engaged in principal business activities including manufacturing and accommodation and food service, with detailed activities including electrical equipment, general purpose and special purpose machinery & equipment, transport equipment, food and beverage services provided by hotels, restaurants, caterers, etc.. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C10 Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment Locked
I Accommodation and Food Service I2 Food and beverage services provided by hotels, restaurants, caterers, etc. Locked
Premium access

Business activity turnover details for Indrayani Biotech Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Indrayani Biotech Limited

Indrayani Biotech Limited is currently managed by 6 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nangavaram Mahadevan Ranganathan Director 20 Aug 2018 7 Years 11 Months Current
Kannimangalam Subramanyan Vaidyanathan Director 20 Aug 2018 7 Years 11 Months Current
Kasiraman Sayee Sundar Managing Director 17 Feb 2018 8 Years 5 Months Current
Bokara Nagarajan Padmaja Priyadarshini Director 26 Mar 2021 5 Years 3 Months Current
Swaminathan Govindarajan Whole-Time Director 01 Aug 2020 5 Years 11 Months Current
Muthukrishnan Ramesh Whole-Time Director 04 Jan 2021 5 Years 6 Months Current

Financials of Indrayani Biotech Limited FY 2025 filings available

Indrayani Biotech Limited reported revenue of ₹130.23 Cr (down 21.66% YoY) for FY 2025.

Revenue · FY 2025
₹130.23 Cr ▼ 21.66%
Profit · FY 2025
-₹6.11 Cr ▼ 158.6%
Computed EBITDA · FY 2025
₹9.39 Cr ▼ 61.93%
Revenue₹ Cr · Consolidated0100200FY 2021: ₹21 Cr21.1FY 2021FY 2022: ₹62 Cr · +192% YoY61.6+192%FY 2022FY 2023: ₹163 Cr · +164.6% YoY163+164.6%FY 2023FY 2024: ₹166 Cr · +2% YoY166+2%FY 2024FY 2025: ₹130 Cr · -21.7% YoY130-21.7%FY 2025
Net Profit₹ Cr · Consolidated-15-10-5051015FY 2021: ₹11 Cr (loss)-11.2FY 2021FY 2022: ₹4 Cr · +139.6% YoY4.4+139.6%FY 2022FY 2023: ₹12 Cr · +168.7% YoY11.9+168.7%FY 2023FY 2024: ₹10 Cr · -12.6% YoY10.4-12.6%FY 2024FY 2025: ₹6 Cr (loss) · -158.6% YoY-6.1FY 2025
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹32 Cr31.5Q1'25Q2'25: ₹31 Cr30.8Q2'25Q3'25: ₹17 Cr17.3Q3'25Q4'25: ₹51 Cr50.6Q4'25Q1'26: ₹29 Cr · -7.7% YoY29.1-7.7%Q1'26Q2'26: ₹36 Cr · +16.7% YoY35.9+16.7%Q2'26Q3'26: ₹35 Cr · +102.2% YoY35+102.2%Q3'26
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹130.23 Cr ₹166.23 Cr ₹162.93 Cr ₹61.57 Cr ₹21.09 Cr
Other Income ₹3.13 Cr ₹1.21 Cr ₹4.49 Cr ₹22.09 Lakh ₹26.5 Lakh
Total Income ₹133.35 Cr ₹167.44 Cr ₹167.41 Cr ₹61.79 Cr ₹21.35 Cr
Cost of Materials Consumed ₹82.77 Cr ₹103.22 Cr ₹102.21 Cr ₹41.04 Cr ₹15.77 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 -₹6.09 Cr ₹0 ₹0 ₹0
Employee Benefit Expense ₹20.47 Cr ₹23.93 Cr ₹23.54 Cr ₹10.22 Cr ₹5.94 Cr
Finance Costs ₹11.76 Cr ₹9.88 Cr ₹5.56 Cr ₹1.88 Cr ₹1.96 Cr
Depreciation & Amortisation ₹3.37 Cr ₹3.8 Cr ₹3.35 Cr ₹65.94 Lakh ₹45.82 Lakh
Other Expenses ₹20.73 Cr ₹21.72 Cr ₹19.95 Cr ₹3.54 Cr ₹4.33 Cr
Total Expenses ₹139.1 Cr ₹156.47 Cr ₹154.61 Cr ₹57.34 Cr ₹28.46 Cr
Profit Before Exceptional Items & Tax -₹5.74 Cr ₹10.97 Cr ₹12.81 Cr ₹4.45 Cr -₹7.11 Cr
Exceptional Items ₹0 ₹0 -₹50 Lakh ₹0 -₹4.11 Cr
Profit Before Tax -₹5.74 Cr ₹10.97 Cr ₹12.31 Cr ₹4.45 Cr -₹11.21 Cr
Total Tax Expense ₹36.4 Lakh ₹55.19 Lakh ₹37.52 Lakh ₹1.24 Lakh ₹0
Net Profit -₹6.11 Cr ₹10.42 Cr ₹11.93 Cr ₹4.44 Cr -₹11.21 Cr
  attributable to Owners - ₹0 ₹8.74 Cr ₹4.43 Cr -₹11.12 Cr
  attributable to NCI - ₹0 ₹3.19 Cr ₹1.2 Lakh -₹9.29 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹6.11 Cr ₹10.42 Cr ₹11.93 Cr ₹4.44 Cr -₹11.21 Cr
EBITDA (computed) ₹9.39 Cr ₹24.66 Cr ₹21.71 Cr ₹6.99 Cr -₹4.69 Cr
Basic EPS ₹-1.35 ₹1.40 ₹2.55 ₹1.30 ₹-3.15
Diluted EPS ₹-1.35 ₹1.40 ₹2.05 ₹1.30 ₹-3.15
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Total Assets ₹268.17 Cr ₹235.03 Cr ₹155.96 Cr ₹51.4 Cr ₹40.05 Cr
Non-current Assets ₹90.23 Cr ₹90.05 Cr ₹78.44 Cr ₹30.46 Cr ₹30.43 Cr
Current Assets ₹177.94 Cr ₹144.98 Cr ₹77.52 Cr ₹20.94 Cr ₹9.62 Cr
Property, Plant & Equipment ₹34.34 Cr ₹39.08 Cr ₹34.11 Cr ₹12.67 Cr ₹11.53 Cr
Inventories ₹41.34 Cr ₹42.35 Cr ₹12.21 Cr ₹1.53 Cr ₹1.09 Cr
Trade Receivables ₹58.69 Cr ₹39.53 Cr ₹29.97 Cr ₹14.1 Cr ₹4.77 Cr
Cash & Equivalents ₹28.82 Lakh ₹58.21 Lakh ₹3.04 Cr ₹5.24 Lakh ₹8.01 Lakh
Equity (Net Worth) ₹99.92 Cr ₹76.27 Cr ₹48.35 Cr ₹24.57 Cr ₹20.08 Cr
Equity Share Capital ₹45.54 Cr ₹45.54 Cr ₹43.48 Cr ₹34.23 Cr ₹34.23 Cr
Borrowings (Non-current) ₹65.42 Cr ₹66.6 Cr ₹29.37 Cr ₹6.79 Cr ₹8.15 Cr
Borrowings (Current) ₹71.66 Cr ₹41.07 Cr ₹33.37 Cr ₹11.1 Cr ₹7.38 Cr
Total Debt (computed) ₹137.07 Cr ₹107.66 Cr ₹62.75 Cr ₹17.89 Cr ₹15.54 Cr
Current Liabilities ₹102.48 Cr ₹87.07 Cr ₹71.91 Cr ₹19.48 Cr ₹11.81 Cr
Total Liabilities ₹168.25 Cr ₹158.76 Cr ₹107.61 Cr ₹26.83 Cr ₹19.97 Cr
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹6.74 Cr -₹30.35 Cr ₹16.19 Cr ₹4.13 Cr
Investing Cash Flow ₹24.74 Cr -₹16.34 Cr -₹47.39 Cr -₹55.79 Lakh
Financing Cash Flow -₹18.3 Cr ₹44.24 Cr ₹32.74 Cr -₹2.74 Cr
Capital Expenditure ₹1.38 Cr ₹16.3 Cr ₹18.25 Cr ₹1.19 Cr
Free Cash Flow (computed) -₹8.12 Cr -₹46.66 Cr -₹2.07 Cr ₹2.94 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹29.39 Lakh -₹2.45 Cr ₹1.53 Cr ₹82.39 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹35.01 Cr ₹35.95 Cr ₹29.1 Cr ₹50.57 Cr ₹17.32 Cr ₹30.81 Cr ₹31.53 Cr
Other Income ₹83.08 Lakh ₹1.8 Cr ₹1.06 Cr ₹2.78 Cr ₹38,000 ₹30.13 Lakh ₹4.43 Lakh
Total Income ₹35.85 Cr ₹37.75 Cr ₹30.16 Cr ₹53.35 Cr ₹17.32 Cr ₹31.11 Cr ₹31.57 Cr
Cost of Materials Consumed ₹26.1 Cr ₹21.94 Cr ₹20.76 Cr ₹38.96 Cr ₹10.05 Cr ₹17.09 Cr ₹16.67 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹1.22 Cr ₹8.64 Lakh -₹2.22 Cr ₹91.33 Lakh
Employee Benefit Expense ₹3.2 Cr ₹3.97 Cr ₹2.69 Cr ₹6.19 Cr ₹3.42 Cr ₹5.14 Cr ₹5.72 Cr
Finance Costs ₹2.47 Cr ₹1.89 Cr ₹2.17 Cr ₹7.07 Cr ₹1.03 Cr ₹1.42 Cr ₹2.25 Cr
Depreciation & Amortisation ₹1.01 Cr ₹1.3 Cr ₹85.82 Lakh -₹1.72 Cr ₹1.46 Cr ₹2.79 Cr ₹82.74 Lakh
Other Expenses ₹2.93 Cr ₹7.59 Cr ₹3.47 Cr ₹9.93 Cr ₹84.96 Lakh ₹5.69 Cr ₹4.25 Cr
Total Expenses ₹35.7 Cr ₹36.69 Cr ₹29.95 Cr ₹61.66 Cr ₹16.89 Cr ₹29.92 Cr ₹30.63 Cr
Profit Before Exceptional Items & Tax ₹14.26 Lakh ₹1.06 Cr ₹20.87 Lakh -₹8.32 Cr ₹43.28 Lakh ₹1.2 Cr ₹94.46 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹14.26 Lakh ₹1.06 Cr ₹20.87 Lakh -₹8.32 Cr ₹43.28 Lakh ₹1.2 Cr ₹94.46 Lakh
Total Tax Expense ₹2.7 Lakh ₹14.83 Lakh ₹5.22 Lakh ₹20.67 Lakh ₹8.13 Lakh -₹1.85 Lakh ₹9.45 Lakh
Net Profit ₹11.56 Lakh ₹91.21 Lakh ₹15.65 Lakh -₹8.53 Cr ₹35.15 Lakh ₹1.22 Cr ₹85.01 Lakh
  attributable to Owners ₹6.36 Lakh - - - ₹23.86 Lakh - ₹0
  attributable to NCI ₹5.2 Lakh - - - ₹11.29 Lakh - ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹11.56 Lakh ₹91.21 Lakh ₹15.65 Lakh -₹8.53 Cr ₹35.15 Lakh ₹1.22 Cr ₹85.01 Lakh
EBITDA (computed) ₹3.62 Cr ₹4.25 Cr ₹3.24 Cr -₹2.96 Cr ₹2.92 Cr ₹5.41 Cr ₹4.02 Cr
Basic EPS ₹0.01 ₹0.09 ₹0.03 ₹-1.42 ₹0.05 ₹0.13 ₹0.10
Diluted EPS ₹0.01 ₹0.09 ₹0.03 ₹-1.42 ₹0.05 ₹0.13 ₹0.10
Latest 7 quarters shown.
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹37.77 Cr ₹62.32 Cr ₹74.48 Cr ₹57.99 Cr ₹21.01 Cr ₹49.9 Cr ₹46.98 Cr
Other Income ₹3.52 Cr ₹3.62 Cr ₹64.19 Lakh ₹22.09 Lakh ₹26.34 Lakh ₹19 Lakh ₹45.04 Lakh
Total Income ₹41.29 Cr ₹65.94 Cr ₹75.12 Cr ₹58.21 Cr ₹21.27 Cr ₹50.09 Cr ₹47.43 Cr
Cost of Materials Consumed ₹14.78 Cr ₹35.15 Cr ₹41.49 Cr ₹39.71 Cr ₹15.76 Cr ₹31.98 Cr ₹29.96 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹50 Lakh ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹13.24 Cr ₹15.69 Cr ₹17.5 Cr ₹8.97 Cr ₹5.71 Cr ₹11.35 Cr ₹11.73 Cr
Finance Costs ₹7.32 Cr ₹4.83 Cr ₹2.78 Cr ₹1.88 Cr ₹1.96 Cr ₹1.15 Cr ₹1.12 Cr
Depreciation & Amortisation ₹1.02 Cr ₹1.45 Cr ₹93.26 Lakh ₹34.43 Lakh ₹40.25 Lakh ₹1.01 Cr ₹1.09 Cr
Other Expenses ₹4.27 Cr ₹5.81 Cr ₹6.84 Cr ₹3.07 Cr ₹4.21 Cr ₹3.29 Cr ₹3.17 Cr
Total Expenses ₹40.64 Cr ₹62.93 Cr ₹69.54 Cr ₹53.98 Cr ₹28.05 Cr ₹49.28 Cr ₹47.07 Cr
Profit Before Exceptional Items & Tax ₹64.63 Lakh ₹3.01 Cr ₹5.58 Cr ₹4.23 Cr -₹6.78 Cr ₹81 Lakh ₹36.34 Lakh
Exceptional Items ₹0 ₹0 -₹50 Lakh ₹0 -₹4.11 Cr ₹0 ₹0
Profit Before Tax ₹64.63 Lakh ₹3.01 Cr ₹5.08 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹36.34 Lakh
Total Tax Expense -₹80 Lakh ₹1.55 Cr ₹2.25 Lakh ₹0 ₹0 ₹0 ₹31.58 Lakh
Net Profit ₹1.45 Cr ₹1.46 Cr ₹5.06 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹4.76 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹1.45 Cr ₹1.46 Cr ₹5.06 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹4.76 Lakh
EBITDA (computed) ₹8.99 Cr ₹9.28 Cr ₹9.3 Cr ₹6.45 Cr -₹4.41 Cr ₹2.97 Cr ₹2.57 Cr
Basic EPS ₹0.00 ₹0.32 ₹1.48 ₹1.23 ₹-3.18 ₹0.24 ₹0.01
Diluted EPS ₹0.00 ₹0.32 ₹1.20 ₹1.23 ₹-3.18 ₹0.24 ₹0.01
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹130.68 Cr ₹126.01 Cr ₹100.3 Cr ₹49.43 Cr ₹39.85 Cr ₹51.47 Cr ₹50.16 Cr
Non-current Assets ₹50.05 Cr ₹54.5 Cr ₹50.97 Cr ₹29.41 Cr ₹30.34 Cr ₹32.28 Cr ₹29.58 Cr
Current Assets ₹80.62 Cr ₹71.5 Cr ₹49.33 Cr ₹20.02 Cr ₹9.51 Cr ₹19.2 Cr ₹20.58 Cr
Property, Plant & Equipment ₹12.83 Cr ₹17.82 Cr ₹19.97 Cr ₹11.49 Cr ₹11.28 Cr ₹13.53 Cr ₹14.02 Cr
Inventories ₹1.69 Cr ₹1.92 Cr ₹1.86 Cr ₹1.37 Cr ₹1.08 Cr ₹5.07 Cr ₹8.52 Cr
Trade Receivables ₹16.46 Cr ₹17.6 Cr ₹16.23 Cr ₹12.88 Cr ₹4.77 Cr ₹7.04 Cr ₹7.93 Cr
Cash & Equivalents ₹6.21 Lakh ₹26.29 Lakh ₹61.9 Lakh ₹3.62 Lakh ₹3.99 Lakh ₹11.08 Lakh ₹2.82 Lakh
Equity (Net Worth) ₹55.33 Cr ₹54.52 Cr ₹51.15 Cr ₹24.18 Cr ₹19.95 Cr ₹30.84 Cr ₹30.03 Cr
Equity Share Capital ₹45.54 Cr ₹45.54 Cr ₹43.48 Cr ₹34.23 Cr ₹34.23 Cr ₹34.23 Cr ₹34.23 Cr
Borrowings (Non-current) ₹13.64 Cr ₹14.88 Cr ₹9.76 Cr ₹6.79 Cr ₹8.15 Cr ₹6.94 Cr ₹7.1 Cr
Borrowings (Current) ₹48.02 Cr ₹44.51 Cr ₹25.51 Cr ₹9.95 Cr ₹7.28 Cr ₹6.8 Cr ₹6.75 Cr
Total Debt (computed) ₹61.66 Cr ₹59.39 Cr ₹35.27 Cr ₹16.73 Cr ₹15.43 Cr ₹13.74 Cr ₹13.85 Cr
Current Liabilities ₹61.48 Cr ₹51.52 Cr ₹33.06 Cr ₹18.46 Cr ₹11.73 Cr ₹13.68 Cr ₹13.02 Cr
Total Liabilities ₹75.35 Cr ₹71.49 Cr ₹49.15 Cr ₹25.26 Cr ₹19.9 Cr ₹20.64 Cr ₹20.13 Cr
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹17.35 Cr ₹26.09 Cr ₹8.39 Cr ₹3.48 Cr
Investing Cash Flow -₹1.34 Cr -₹7.22 Cr -₹14.09 Cr ₹58.63 Lakh
Financing Cash Flow -₹16.22 Cr -₹19.23 Cr ₹4.87 Cr -₹3.25 Cr
Capital Expenditure ₹85.07 Lakh ₹6.34 Cr ₹1.9 Cr ₹6.31 Lakh
Free Cash Flow (computed) ₹16.5 Cr ₹19.75 Cr ₹6.49 Cr ₹3.42 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹20.08 Lakh -₹35.61 Lakh -₹82.64 Lakh ₹81.87 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹5.2 Cr ₹5.93 Cr ₹6.69 Cr ₹9.28 Cr ₹8.19 Cr ₹9.51 Cr ₹10.79 Cr
Other Income ₹67.66 Lakh ₹1.82 Cr ₹89.16 Lakh ₹93.41 Lakh ₹66.21 Lakh ₹89.38 Lakh ₹1.03 Cr
Total Income ₹5.88 Cr ₹7.75 Cr ₹7.58 Cr ₹10.22 Cr ₹8.85 Cr ₹10.4 Cr ₹11.82 Cr
Cost of Materials Consumed ₹2.04 Cr ₹3.06 Cr ₹3.35 Cr ₹2.8 Cr ₹3.34 Cr ₹3.8 Cr ₹4.85 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹1.38 Cr ₹1.56 Cr ₹1.5 Cr ₹3.3 Cr ₹2.69 Cr ₹3.2 Cr ₹4.04 Cr
Finance Costs ₹1.09 Cr ₹99.22 Lakh ₹1.32 Cr ₹2.39 Cr ₹1.52 Cr ₹1.89 Cr ₹1.52 Cr
Depreciation & Amortisation ₹14.23 Lakh ₹16.51 Lakh ₹15.25 Lakh ₹6.41 Lakh ₹32.34 Lakh ₹31.76 Lakh ₹31.98 Lakh
Other Expenses ₹1.12 Cr ₹1.36 Cr ₹1.08 Cr ₹1.46 Cr ₹82.36 Lakh ₹1.06 Cr ₹92.93 Lakh
Total Expenses ₹5.77 Cr ₹7.13 Cr ₹7.41 Cr ₹10.01 Cr ₹8.71 Cr ₹10.27 Cr ₹11.65 Cr
Profit Before Exceptional Items & Tax ₹10.72 Lakh ₹62.62 Lakh ₹17.03 Lakh ₹20.24 Lakh ₹14.18 Lakh ₹13.16 Lakh ₹17.05 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.72 Lakh ₹62.62 Lakh ₹17.03 Lakh ₹20.24 Lakh ₹14.18 Lakh ₹13.16 Lakh ₹17.05 Lakh
Total Tax Expense ₹2.7 Lakh ₹15.79 Lakh ₹4.26 Lakh ₹0 ₹3.57 Lakh ₹3.27 Lakh ₹4.33 Lakh
Net Profit ₹8.02 Lakh ₹46.83 Lakh ₹12.77 Lakh ₹20.24 Lakh ₹10.61 Lakh ₹9.89 Lakh ₹12.72 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹8.02 Lakh ₹46.83 Lakh ₹12.77 Lakh ₹20.24 Lakh ₹10.61 Lakh ₹9.89 Lakh ₹12.72 Lakh
EBITDA (computed) ₹1.34 Cr ₹1.78 Cr ₹1.64 Cr ₹2.66 Cr ₹1.99 Cr ₹2.33 Cr ₹2.01 Cr
Basic EPS ₹0.01 ₹0.10 ₹0.03 ₹0.00 ₹0.02 ₹0.02 ₹0.03
Diluted EPS ₹0.01 ₹0.10 ₹0.03 ₹0.00 ₹0.02 ₹0.02 ₹0.03
Latest 7 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Indrayani Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Indrayani Biotech Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 33.26%, domestic institutional investors hold 3.13%, retail and other public shareholders hold 63.61% of Indrayani Biotech Limited. The company had 25,509 shareholders on record.

Promoters: 33.26%DII (Domestic Institutional): 3.13%Retail & Others: 63.61%
Mar 2026
QUARTER
33.26% Promoters
3.13% DII (Domestic Institutional)
63.61% Retail & Others
Promoter holding - history
Now 33.26% · Mar 2026High 44.89% · Jun 2023Low 33.26% · Sep 2025
32%35.5%39%42.5%46%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 44.89%Sep 2023: 44.84%Dec 2023: 33.63%Mar 2024: 33.57%Jun 2024: 33.48%Sep 2024: 33.40%Dec 2024: 33.28%Mar 2025: 33.28%Jun 2025: 33.28%Sep 2025: 33.26%Dec 2025: 33.26%Mar 2026: 33.26%44.89%33.26%33.26%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters33.26%33.26%33.26%33.28%33.28%33.28%
Public66.74%66.74%66.74%66.72%66.72%66.72%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters33.26%33.28%33.57%
Public66.74%66.72%66.43%
Promoter change (YoY, %pts)-0.02-0.29-

Group Structure of Indrayani Biotech Limited

Indrayani Biotech Limited has 9 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Indrayani Biotech Limited's business expansion strategy and organizational complexity.

9
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Hsl Agri Solutions Limited U01100TN2018PLC121939 -
Dindigul Farm Product Private Limited U15200TZ2010PTC016407 -
Matrix Boilers Private Limited U28131TN2006PTC060358 -
Ibl Investments Limited U65990TN2022PLC152486 -
Hslprime Properties Private Limited U70103TN2017PTC114104 -
Healthway India Private Limited U74900TN2013PTC091433 -

Showing major subsidiaries. Total: 9.

Charges & Borrowings of Indrayani Biotech Limited

Open charges
₹23.62 Cr
Satisfied charges
₹1.16 Cr
Breakdown by lending institutions
Others₹13.25 Cr
Axis Bank Limited₹10.00 Cr
Hdfc Bank Limited₹0.37 Cr
Latest charge details
DateLenderAmountStatus
13 Mar 2026 Others ₹2 Cr Open
26 Feb 2024 Hdfc Bank Limited ₹37 Lakh Open
21 Jan 2023 Others ₹7 Cr Open
08 Dec 2022 Others ₹19 Lakh Open
16 Nov 2022 Others ₹8.58 Lakh Open

Total charge records: 14 View all charges

Employees and EPFO Compliance at Indrayani Biotech Limited

Indrayani Biotech Limited has a workforce of 445 employees as of Apr 09, 2024.

Employee count
445
Active EPFO establishments
2
Employee growth
9.61%
Premium access

Employee and EPFO history for Indrayani Biotech Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Indrayani Biotech Limited

Premium access

GST registrations and filing compliance for Indrayani Biotech Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Indrayani Biotech Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Indrayani Biotech Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Indrayani Biotech Limited

Premium access

MSME payment history for Indrayani Biotech Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Indrayani Biotech Limited

Premium access

Corporate group structure for Indrayani Biotech Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Indrayani Biotech Limited

Premium access

MCA filings and documents for Indrayani Biotech Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Indrayani Biotech Limited

Directors
06 Apr 2026
Kunisetty Venkateswararao was appointed as a Cfo on 06 Apr 2026 & has been associated with this company since 3 months 16 days.
Charges
17 Mar 2026
A charge with Others of Rs. 2.00 Cr registered on 13 Mar 2026 with Charge ID 101271704 was modified on 17 Mar 2026.
Charges
13 Mar 2026
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101271704 was registered on 13 Mar 2026.
Charges
23 Dec 2025
A charge registered on 26 Apr 2022 via Charge ID 100576294 with Others was fully satisfied on 23 Dec 2025.
Charges
23 Dec 2025
A charge registered on 26 Apr 2022 via Charge ID 100590098 with Others was fully satisfied on 23 Dec 2025.
Charges
08 Dec 2025
A charge registered on 26 Apr 2022 via Charge ID 100590747 with Others was fully satisfied on 08 Dec 2025.

Recent News on Indrayani Biotech Limited

Frequently Asked Questions about Indrayani Biotech Limited

Indrayani Biotech Limited is an active public limited company in the agriculture sector based in Chennai, Tamil Nadu, India. It was incorporated on 09 March 1992 (34+ years old) and is registered under CIN L40100TN1992PLC129301. Listed on BSE: 526445. The company has 445 employees.

Indrayani Biotech Limited reported revenue of ₹130.23 Cr for FY 2025 (down 21.66% YoY) based on consolidated BSE filings.

The current directors of Indrayani Biotech Limited are:

The primary industry of Indrayani Biotech Limited is agriculture. The company specifically operates in fertilizers and soil enhancers. The company is currently active in this sector.

Yes. Indrayani Biotech Limited is listed on BSE with code 526445.

Indrayani Biotech Limited can be reached at the registered office: Block 1 Module No.33 3Rd Floor Sidco Electronic Complex Thiru Vi Ka Industrial Estate G, Uindy, Chennai, Tamil Nadu, India – 600032, or through the website indrayani.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available